Loading…

Medical Research Finder

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

Camicinal & Gastroparesis

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Camicinal, another motilin receptor agonist, has been shown to improve Gastric emptying / Gastrointestinal physiology in Diabetic Gastroparesis without a decrease in response after 28 d of use
Navas et al. 2019 Gastrointest Endosc Clin N Am 29: 55-70
…

Prokinetic Effects and Symptom Relief in the Pharmacotherapy of Gastroparesis
Tack et al. 2020
Symptomatic Management of Gastroparesis
Navas et al. 2019 Gastrointest Endosc Clin N Am 29: 55-70
The effect of camicinal (GSK962040), a motilin agonist, on gastric emptying and glucose absorption in feed-intolerant critically ill patients: a randomized, blinded, placebo-controlled, clinical trial
Chapman et al. 2016 Critical Care. 20 (1): 232
The effects of camicinal, a novel motilin agonist, on gastro-esophageal function in healthy humans-a randomized placebo controlled trial
Hobson et al. 2015 Neurogastroenterology and Motility 27(11): 1629–37
The investigational drug camicinal for the treatment of gastroparesis
Barshop & Kuo 2015 Expert Opinion on Investigational Drugs. 24 (1): 133-140

7/1/2026